Efficacy and Safety of Aripiprazole in Patients With First Episode Psychosis: an Open-label, Prospective Multi-center Study.
Phase of Trial: Phase IV
Latest Information Update: 18 Jan 2018
At a glance
- Drugs Aripiprazole (Primary)
- Indications Psychotic disorders; Schizoaffective disorder; Schizophrenia
- Focus Therapeutic Use
- 10 Feb 2012 Actual patient number (55) added as reported by ClinicalTrials.gov.
- 10 Feb 2012 Actual end date (Feb 2012) added as reported by ClinicalTrials.gov.
- 10 Feb 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.